About Pricing FAQs Providers Blog

Loading clinical trials...

Your health journey, clearly organized.

Find Clinical Trials →

Legal

Privacy Policy
Terms of Service

© 2026 Clareo Health. All rights reserved.

Lipids and Insulin Sensitivity | Clinical Trials | Clareo Health

Back to clinical trial search

COMPLETEDNANCT01466816

Lipids and Insulin Sensitivity

Rationale: The investigators hypothesize that a change in dietary fat quality (an increase in unsaturated fatty acids) may modulate fuel partitioning within the type 2 diabetic muscle towards less acc...

Lead sponsor: Maastricht University Medical Center•1 locations•View source on ClinicalTrials.gov

Clareo plain-language summary

What this study is about

Generating AI summary...

Save this trial guide to your notes

Keep your clinical trial research organized — questions to ask, what to expect, and key details.

Sponsors

Lead Sponsor

Maastricht University Medical Center

Age

35 - 70 years

Sex

MALE

Healthy Volunteers

Yes

Inclusion Criteria

•Obese males aged between 35 and 70 years with insulin resistance.

Exclusion Criteria

•History of type 2 diabetes.
•Liver or kidney failure.
•Diseases in which the live expectation is shorter then 5 years.
•The use of experimental medication.
•Diseases/medication use that may have an influence on the glucose tolerance.
•Not to be able to understand the study information.
•Users of fatty acid supplements including fish oils etc.
•Users of high doses of antioxidant vitamins.
•Athletes.
•People on a diet of people that are planning to lose weight.

Related studies

Five PLus Year EffIcacy of Endoscopic Sleeve Gastroplasty (ESG) for Sustained WeigHT Loss

NCT06894498 · Obesity and Obesity-related Medical Conditions, Weight Loss

Intensive Glycemic Targets in Overweight and Obese Women With Gestational Diabetes

NCT05124808 · Gestational Diabetes, Pregnancy, High Risk, and more

RECRUITINGPhase 3

Mirikizumab Administered at the Same Time as Tirzepatide in Adult Participants With Moderately to Severely Active Ulcerative Colitis and Obesity or Overweight: Phase 3b Study

NCT06937086 · Ulcerative Colitis, Obesity or Overweight

RECRUITINGPhase 3

A Study to Learn About the Study Medicine Called Berobenatide (PF-08653944) in People With Overweight or Obesity

NCT07595549 · Obesity, Overweight and/or Obesity, and more

RECRUITINGPhase 3

Efficacy and Safety of KAI-9531 in Participants Living With Obesity or Overweight With Weight-Related Comorbidities Who Do Not Have Diabetes

NCT07284875 · Obesity, Overweight

View all related studies →

Data from ClinicalTrials.govLast updated on ClinicalTrials.gov: November 8, 2011Terms

Trial snapshot

StatusCOMPLETED

PhaseNA

Enrollment10

Start dateOct 2008

Last updatedNov 8, 2011

Condition

Obesity Insulin Resistance

Locations shown

Maastricht University Medical Centre +

Maastricht, Limburg

For caregivers

Use Clareo to keep notes, questions, trial details, and next steps organized before and after appointments.

Start free trial →

Data Source & Attribution

This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.

ClinicalTrials.gov last update: November 8, 2011Data synced to Clareo: July 13, 2026

Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.

Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.

View ClinicalTrials.gov Terms and Conditions